Skip to main content
Premium Trial:

Request an Annual Quote

ABI Plans to Introduce Off-the-Shelf Assays

SAN FRANCISCO, Jan. 10 - Applied Biosystems plans to introduce a new Assays-On-Demand product beginning in June, company officials said here on Thursday.  


The kits, designed to assess gene expression, SNP genotyping, and exons of known genes, will be available to order on ABI's e-commerce website, said Steve Lombardi, the firm's senior vice president of applications and products.


The pre-made assays join ABI's Assays-By-Design and the recently introduced 4700 Proteomics Analyzer as new products meant to address shifts in genomics and proteomics research.


"The assays are predefined and validated," said Lombardi. "[You] end up taking a process that could take months and getting it down to a few days."


"I think [the assays] will be a big deal," said Scott Greenstone, vice president of equity research at Thomas Weisel Partners. "It's a higher value product for them and there's a trend for pre-made assays."


The assays are part of a shift to ABI "providing more content-based products," said Michael Hunkapiller, president of Applied Biosystems.


But "can they overcome a decline in instrument placements?" asked Greenstone. "It is a difficult road for them to get back to 20 percent [revenue growth]."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.